Our data by showing the combined decreased percentage of CXCR5+ and decreased expression of CD19 - particularly in the double negative (CD27-IgD-) B cell subset - which associate with disease activity support the contribution of extrafollicular B cell expansion to SLE pathogenesis as elegantly proposed by others [53]. The gene discussed is CD19; the disease is systemic lupus erythematosus.